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Abstract ‘Polypoid endometriosis’ is a rare variant of
endometriosis. We describe a case of an extremely large
polypoid endometriosis mimicking a malignant tumor. A
37-year-old nulliparous woman was referred due to the
rapid growth of an endometriotic cyst of the ovary and a
high serum CA125 level. MRI revealed solid components
in the pelvic mass. These preoperative clinical data were
compatible with an ovarian carcinoma. A frozen section of
the tumor biopsy showed as if an adenosarcoma, but finally
the diagnosis of polypoid endometriosis with decidual
change was made on permanent section. Polypoid en-
dometriosis is a part of the differential diagnosis for ma-
lignant tumors in women with endometriosis, and we
should consider carefully decision making for treatment.
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Introduction
Endometriosis is a relatively common disease among
women of childbearing age. However, ‘polypoid en-
dometriosis’ is a considerably rare form of endometriosis
that may mimic a neoplasm on clinical, intraoperative, and
gross examination [1].
Here, we report a case of huge polypoid endometriosis
that grew rapidly occupying the whole pelvis and made it
difficult to make a proper diagnosis.
Clinical summary
A 37-year-old nulliparous woman was referred due to a
rapid growth of an endometriotic cyst of the ovary and a
high serum CA125 level. The ovarian mass had grown
from 3 to over 20 cm in 6 months, and the serum CA125
level elevated to 3263 U/ml (normal\35 U/ml). She had a
long history of various hormonal therapies and repeated
laparotomy for severe endometriosis. She had no history of
treatment with Tamoxifen. Magnetic resonance imaging
(MRI) revealed solid components in the mass to have high
signal intensity on T2-weighted imaging (Fig. 1) and ir-
regular thickness of the omentum and the peritoneum.
These clinical findings made us consider a malignant
ovarian tumor, especially a papillary serous adenocarci-
noma with peritonitis carcinomatosa. A surgical abdominal
exploration revealed a huge polypoid mass occupying most
of the pelvis, and a frozen section suggested an adenosar-
coma. However, the permanent sections of surgically re-
sected mass disclosed that the lesion was polypoid
endometriosis.
Macroscopic findings
The cauliflower-like polypoid mass arose from the serosa
of the uterus and was whitish yellow in color and 20 cm
(Fig. 2a). Both ovaries were cystic with chocolate-colored
fluid (Fig. 2b). Whitish small foci were also found in the
omentum and the peritoneum.
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Microscopic findings
The polypoid lesion was covered with monolayered
columnar to cuboidal epithelial cells on the surface and had
a dense cellular stroma under the epithelial layer (Fig. 3a).
The polypoid lesion of more than half of the tissue was
occupied by stroma. This dense cellular stroma mainly
consisted of polygonal cells having abundant cytoplasm
and enlarged nucleus with prominent nucleoli (Fig. 3b).
Such cells were positive for vimentin and estrogen recep-
tor. A few cells were positive for CD10. MIB-1 index was
5 % (Fig. 4a–d). We found that this stroma, extended one-
third of whole stroma roughly, showed decidual reaction.
The internal part of polypoid lesion was composed of an
admixture of endometriotic glands and stroma. There were
some areas composed of endometrium-like tissue showing
the secretory phase (Fig. 5). The typical endometriosis was
seen in both ovaries, serosa of the uterus, omentum, and
peritoneum. Based on these microscopic findings, the di-
agnosis of polypoid endometriosis with frequent decidual
change was made.
Discussion
The term ’polypoid endometriosis’ was first used by
Mostoufizadeh and Scully [1] in 1980. They described
polypoid endometriosis as ‘‘endometriotic tissue with his-
tologic features simulating those of an endometrial polyp,
and rarely, polypoid masses of endometriosis not only
simulate malignant tumors at operation but may also recur
after operative removal.’’
Because of the rarity, there was only one large series on
such cases, in which Parker et al. [6] performed 24 cases of
clinicopathologic analysis. According to their study, the
mean age of the patients was 52.5 years: 60 % were older
than 50 years, that is to say that this variant of en-
dometriosis emerged among the elder generation compared
with the age range of 25–30 years in the conventional type
[7]. Occasionally, polypoid endometriosis was involved in
multiple sites and the most common sites were the large
bowel and the ovary. Regarding the gross findings, the
maximal size of lesions ranged from 0.4 to 14 cm,
Fig. 1 Pelvic MRI: T2-
weighted imaging shows
irregular shaped mass with solid
components occupying the
whole pelvis
Fig. 2 Macroscopic findings: a cauliflower-like polypoid mass
arising from the serosa of the uterus. b Both ovaries are present
separately from the tumor
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appeared as polypoid masses and had a cystic part in half of
the cases [6]. The cause of polypoid endometriosis is still
not clear; however, some cases may be ascribed to estro-
genic hormonal stimulation. Parker et al. [6] stated that
eleven women in 24 had been taking exogenous estrogen
hormones after menopause. Meanwhile, Schlesinger
et al. [8] mentioned a correlation between polypoid en-
dometriosis and tamoxifen. Tamoxifen, which is widely
used as an adjuvant therapy for breast cancer, exhibits an
anti-estrogen effect on the breast while being an agonist on
the uterus. Several cases [9, 10] of polypoid endometriosis
in tamoxifen users can support that hyperestrinism is one of
Fig. 3 Microscopic findings:
the polypoid lesion consisted of
endometriosis with decidual
change. a The tumor is covered
with monolayered columnar
epithelia on the surface. A dense
cellular layer and relatively
loose cellular layer were located
under the epithelial layer.
b Stromal cells are polygonal
having abundant cytoplasm and
an enlarged nucleus with
prominent nucleoli
Fig. 4 Immunochemical findings: a estrogen receptor is positive on most epithelial and stromal cells, b a few stromal cells are positive for
CD10, c most stromal cells are strongly positive for vimentin, d MIB-1 index is 5 %
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Fig. 5 Some parts of the tumor
are composed of endometrium-
like tissue showing the secretory
phase
Table 1 Polypoid endometriosis: review of the literature
References Age (years) Location Hormonal status Size of the biggest mass (cm)
Mostoufizadeh and Scully [1] 65 Both ovaries, pelvic tissue None NA
47 Vagina None 12
55 Cervical os ERT NA
Chang and Natarajan [3] 58 Endometrium ERT 2
Kaushal et al. [4] 27 Vagina None 3.5
Lambrechts et al. [5] 29 Bladder During pregnancy 3
Parker et al. [6]. 55 Ureter and vagina ERT NA
63 Adnexa None 4
64 Uterine serosa None 10
43 Peritoneum ERT 13
34 Retroperitoneum ERT 8
67 Colonic mesentery None 1.2
57 Cervix and vagina None 14
60 Ovary EPRT 0.9
78 Pelvic endometriosis None NA
74 Omentum ERT 5
43 Ovary None 10
59 Ovary None NA
40 Colonic mucosa None 7
NA Colonic mucosa None 3
39 Peritoneum None 8
53 Colonic wall and peritoneum ERT 7
23 Pelvic endometriosis None 12
62 Ovary ERT 7.2
55 Uterine serosa None 4.5
52 Ovary ERT 7
56 Ureter None 1.6
40 Vagina EPRT 3
45 Vagina None 2
46 Colonic mucosa None 4
Schlesinger and Silverberg [8] 65 Cervix and ovary Tamoxifen NA
Kraft and Hughes et al. [9] 47 Ovary Tamoxifen NA
Chang et al. [10] Premenopause Pelvic endometriosis Tamoxifen 6
Othman et al. [11] 26 Endometrium GnRH agonist NA
Marugami et al. [12] 45 Ureter GnRH agonist
Current case 37 Uterine serosa Various 20
NA not available, EPRT estrogen progestin replacement therapy, ERT estrogen replacement therapy
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the causes of this disease. Furthermore, Othman et al. [11]
reported a case of polypoid endometriosis following go-
nadotrophin-releasing hormone (GnRH) agonist. They
postulated that the lesion developed as a rebound phe-
nomenon upon withdrawal of GnRH agonist-induced hor-
monal suppression [12].
In view of pathological characteristics, Parker et al.
defined polypoid endometriosis as ‘‘an admixture of be-
nign, but sometimes atypical, appearing endometriotic
glands and benign-appearing endometriotic stroma.’’ With
regard to the stroma, stromal cell atypia was not observed
in any case and in most cases appeared in the proliferative
phase stroma. Focal decidual change and increasing stro-
mal cellularity were also noted in some cases [6]. The main
differential diagnosis should be an adenosarcoma. Micro-
scopic characteristics of adenosarcoma are Mu¨llerian-type
glands without atypia in the malignant stromal component,
periglandular cuffs of cellular stroma, and variable mitotic
count [13, 14].
In the present case, the patient had been regularly
checked for endometriosis since she was young. She had
received laparotomy twice, and then in each resected tissue
endometriosis without any evidence of malignancy was
pathologically proved. While she had received several
surgical treatments, she had also a variety of hormonal
therapies such as oral contraceptives, GnRH agonist, and
progestins rotationally. Administration of the oral pro-
gestins had been interrupted 6 months prior to her ap-
pearance at our hospital. Through her regular follow-up in
these 6 months, the pelvic mass, considered to be an en-
dometriotic cyst of the ovary at this point, grew from 3 to
20 cm, changed its shape with solid components, and the
serum CA125 level rose gradually. These clinical findings
convinced us of the presence of malignancy.
Compared to literature cases [1–12] (Table 1), our case
was younger, considerably huge in size, and the lesions
developed in the pelvis rapidly as soon as there was a break
of hormonal therapy. The cause of this rapid growth of
lesions is uncertain, but interruption of hormonal treatment
could have contributed to hyperestrinism and raised poly-
poid masses in this case. The main mass was covered with
epithelial cells without atypia, and stromal cells were
mildly dense with enlarged nucleus with prominent nu-
cleoli. Such findings led to a misdiagnosis of Mu¨llerian
adenosarcoma from frozen sections. We finally concluded
that the mass was a polypoid endometriosis with decidual
change since stromal atypia was mild and the MIB-1 index
was 5 % on permanent sections. Probably, decidual change
was caused by the prior progestin therapy or spontaneous
ovulation in this case. We assume that decidualized stromal
cells appeared as if a sarcomatous component.
In conclusion, polypoid endometriosis is a part of the
differential diagnosis for malignant tumors in women with
endometriosis. We should be aware of the difficulty of
making proper diagnosis pre- and intraoperatively and
consider carefully decision making for treatment, espe-
cially for young women.
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